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Abstract
Treatment for clinical schistosomiasis has relied centrally on the broad spectrum anthelmintic praziquantel; however, there
is limited information on its mode of action or the molecular response of the parasite. This paper presents a transcriptional
and functional approach to defining the molecular responses of schistosomes to praziquantel. Differential gene expression
in Schistosoma japonicum was investigated by transcriptome-wide microarray analysis of adult worms perfused from
infected mice after 0.5 to 24 hours after oral administration of sub-lethal doses of praziquantel. Genes up-regulated initially
in male parasites were associated with ‘‘Tegument/Muscle Repair’’ and ‘‘Lipid/Ion Regulation’’ functions and were followed
by ‘‘Drug Resistance’’ and ‘‘Ion Regulation’’ associated genes. Prominent responses induced in female worms included up-
regulation of ‘‘Ca2+ Regulation’’ and ‘‘Drug Resistance’’ genes and later by transcripts of ‘‘Detoxification’’ and ‘‘Pathogen
Defense’’ mechanisms. A subset of highly over-expressed genes, with putative drug resistance/detoxification roles or Ca2+-
dependant/modulatory functions, were validated by qPCR. The leading candidate among these was CamKII, a putative
calcium/calmodulin-dependent protein kinase type II delta chain. RNA interference was employed to knockdown CamKII in
S. japonicum to determine the role of CamKII in the response to praziquantel. After partial-knockdown, schistosomes were
analysed using IC50 concentrations (50% worm motility) and quantitative monitoring of parasite movement. When CamKII
transcription was reduced by 50–69% in S. japonicum, the subsequent effect of an IC50 dosage of praziquantel was
exacerbated, reducing motility from 47% to 27% in female worms and from 61% to 23% in males. These observations
indicated that CamKII mitigates the effects of praziquantel, probably through stabilising Ca2+ fluxes within parasite muscles
and tegument. Together, these studies comprehensively charted transcriptional changes upon exposure to praziquantel
and, notably, identified CamKII as potentially central to the, as yet undefined, mode of action of praziquantel.
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Introduction
At least 200 million people are afflicted by schistosomiasis [1],
where clinical symptoms associated with the disease range from
fever, headache and lethargy, to severe fibro-obstructive patho-
logical changes, portal hypertension, ascites and hepatospleno-
megaly, with complications that are frequently fatal. Meta-analysis
indicates that the disease burden, in terms of morbidity and
mortality is far greater than previously estimated [1]. Current
public health approaches to control of schistosomiasis is under-
pinned by mass or targeted drug treatment with the heterocyclic
pyrazino-isoquinoline compound, praziquantel (PZQ). Since the
1980s, treatment for schistosomiasis has relied almost exclusively
on this broad spectrum anthelmintic, which is safe, effective
against all species, is administered orally, has minimal side effects
and is inexpensive. Remarkably, however, there is only limited
information on the mode of action of PZQ or how schistosome
parasites respond to the drug. With the increasing spread of
schistosomiasis and the concomitant extensive deployment of
PZQ, a menacing spectre of appearance and spread of drug
resistant schistosomes is a worrisome concern.
Early effects of PZQ on Schistosoma mansoni worms include
contraction and paralysis, which may result from membrane
depolarisation and the influx of extracellular calcium [2]. These
effects are compounded by uncontrolled muscle tension which
results in adult worms being flushed from the mesenteric venules
back to the liver, where vacuolisation and disintegration of the
schistosome surface and leukocyte migration through the tegument
can be readily observed [2]. Sex specific sensitivities for in vitro and
in vivo PZQ exposure are seen in S. mansoni; males are more
sensitive than females to PZQ [3]. PZQ also disrupts Ca2+
homeostasis in schistosomes by an unknown mechanism [4].
Greenberg and colleagues have suggested that PZQ sensitivity in
schistosomes is brought about via the beta-subunit variant of the
Ca2+channel (Cavß), which results in a massive influx of calcium
ions. Competitive binding of Ca2+ channels with cytochalasin D
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(an actin disruptor) interferes with the effects of PZQ, particularly
in adult male worms via the disruption of Ca2+ homeostasis,
subsequently impacting on the tegument actin cytoskeleton [5]. In
addition, expression of ATP-binding cassette (ABC) superfamily
proteins in schistosomes, including multidrug resistance-associated
protein 2 (SMDR2), is altered in worms exposed to sub-lethal
levels of PZQ [6,7]. SMDR2 is also expressed at higher levels in
parasite isolates with reduced PZQ sensitivity, and this protein
interacts directly with PZQ [6,7]. Cioli and colleagues [8]
hypothesised, however, that calcium influx represents only one
component of a complex mechanism which leads to the anti-
schistosomal effects of PZQ. Despite these and other documented
effects of PZQ, the precise identity and location of the molecular
targets of PZQ remain unknown [4].
Genetic crosses of resistant and susceptible strains of S. mansoni
has revealed that PZQ insensitivity is a quantitative trait,
indicating that there may be more than one major physiological
target of the drug [9]. Cioli and colleagues [9] speculated that drug
metabolism could be the key feature of resistance, rather than the
result of significant structural changes to the drug target itself. This
notion is supported by earlier findings that revealed an accumu-
lation of fluorescent substrates within the schistosome and an
increase in the expression of several ABC transport proteins
following exposure to PZQ [10]. Although resistance might also
arise from a mutation or structural change in the drug target,
resulting in decreased binding [11], other features might be
relevant. These could include drug accessibility to tegumental and
other schistosome cells. Alternatively, PZQ might be cleared
through an up-regulation of antioxidant enzymes. Selective
advantage of rare alleles encoding these defences could give rise
to multi-drug resistance, as has occurred parasitic nematodes and
protozoans [12]. Changes in transcriptional levels of the drug
target, rather than a direct mutation, have been suggested as a
mechanism for pyrantel resistance in Ancylostoma caninum with
resistant hookworms down-regulating expression of a nicotinic
acetylcholine receptor [13].
Some information is available on transcription of genes associated
with calcium homeostasis and putative PZQ resistance mechanisms
in S. mansoni. One report described transcriptomic responses to PZQ
and included in vitro culture of adult schistosomes and microarray
analysis, which identified 607 up-regulated genes, 247 of which were
shown to correlate with known oxidative-stress processes and
calcium regulation [14]. PZQ displays a bimodal spectrum of
activity, in that it is active against newly transformed schistosomules
(,3 days old), inactive against immature 21 day-old worms, and full
activity against the sexually mature blood flukes [15]. Recently,
Hines-Kay and colleagues utilised transcriptomics to address this
refractory/susceptible nature of developmental stages of schisto-
somes in terms of PZQ activity [16]. The study profiled gene
expression in adult and juvenile S. mansoni with and without in vitro
PZQ exposure. The findings suggested that juveniles, which are
refractory to PZQ, display enhanced transcriptomic elasticity in the
percentage of differentially expressed genes which the authors
hypothesise endows the immature stages of schistosomes with the
means to withstand the anthelmintic effects of PZQ. Here we
describe the use of a novel approach to examine the transcriptional
responses of adult S. japonicum parasites exposed in vivo to a
combination of PZQ and the host immune system [17,18].
Results
Microarray analysis
Microarray gene expression analyses were undertaken to
investigate the sub-lethal effects of PZQ on S. japonicum in vivo.
Hybridisations were performed on mRNA isolated from male or
female adult parasites for each time point to allow the
identification of 6$2-fold differentially expressed genes, relative
to controls (time point 0). For female worms, 264 genes were up-
regulated between 30 min and 4 h, increasing to 1,009 genes
between 12 and 24 h after drug exposure. PZQ had a broader
effect on transcription in males with 1,508 genes up-regulated at
30 min, increasing to 2,718 genes at 24 h post-drug exposure. The
number of differentially expressed genes are summarised in Table 1
and notable examples of differentially expressed genes are
presented in Table S1. Distinct transcriptional responses by adult
S. japonicum to PZQ were sex-dependent and varied with the
duration of PZQ exposure (Figure 1). A list of all the differentially
expressed genes is presented in Table S2. A comparison of similar
gene expression patterns between the genders was performed.
Using a 2 fold cut of differential regulation compared to time point
0 controls, this included gene expression common to both male
and female parasites as grouped for 30 minute or 4 hour time
points as early responses and 12 hour or 24 h points as later
responses (Table S3). Up-regulated genes (for both sexes) including
19 early, 60 later, and 7 both early and later. By contrast, down-
regulated genes common between the sexes included 380 early,
175 later, and 38 that were modulated consistently during early
and later time points. Some novel genes were observed both at
early and later intervals to be, consistently differentially expressed
in both sexes in response to PZQ exposure. This included up-
regulated Contig06312 (Dual specificity protein kinase CLK1)
which contains a PKc like superfamily motif, and Contig03692
(Early growth response protein 1) which has zinc and nucleic acid
binding functions. Down-regulated genes for both sexes and across
the entire time course, were more numerous; these included
Contig05338 (Exportin-2) a gene related to cell proliferation, and
a number of genes associated with ion transport Contig04920
(Cation/acetate symporter) Contig07059 (Solute carrier family 22
member 3) Contig01777 (Probable cation-transporting P-type
Author Summary
Schistosome infected mice were treated orally with a
single sub-lethal dose of the anthelmintic praziquantel.
Parasites were subsequently isolated 0.5–24 hours later
and analysed by gene expression microarray. The tran-
scriptional pattern was influenced by the sex of the
parasite. Males up-regulated genes associated with surface
integrity, muscle function, ion regulation and drug
resistance. While for female worms, genes associated with
calcium regulation, drug resistance, detoxification and
pathogen defense were transcriptionally elevated. Based
on these findings, genes with putative ion homeostasis or
drug metabolism roles were further investigated for their
prospective roles praziquantel action, using the gene
silencing procedure RNA interference. The leading gene
was CamKII (calcium/calmodulin-dependent protein kinase
type II), a member of the Calcium Signalling Pathway. A
quantitative assay for parasite motility during praziquantel
exposure was used to study worms in which the CamKII
gene had been partially silenced. When CamKII transcrip-
tion was reduced, the effects of praziquantel were
augmented, visualised by reduced parasite movement.
These functional studies indicate a key role for the kinase
CamKII in the mode of action of the praziquantel, and
suggest that future studies on this enzyme and other
calcium signaling pathway components will be construc-
tive in understanding how praziquantel kills schistosomes.
CamKII and Schistosome Responses to Praziquantel
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ATPase) Contig07303 (Uncharacterized symporter) and Con-
tig03785 (Uncharacterized sodium-dependent transporter).
Calcium Signalling Pathway
The differential expression of Contigs with KEGG annotation
associated with the ‘‘Calcium Signalling Pathway’’, were mapped
to present an overview of how PZQ impacts on the pathway as a
whole, as illustrated in Figure 2. Generally, most genes of the
pathway were up-regulated for male S. japonicum but down-
regulated for female worms over the 24 h observation period, with
notable exceptions, including CamKII (Contig01285) which was
up-regulated in both males and females (Table S4).
Real-time PCR validation of microarray findings
To validate these findings of differential expression, nine genes
were analysed further by quantitative (q) PCR. The relative fold
change of gene expression obtained by microarray and by
quantitative PCR was similar for the majority of data points for all
nine genes (Figure S1). The microarray and quantitative PCR data
sets of the nine genes indicated a significant correlation (alpha=0.05)
between the twomethods (Spearman’s Rho=0.83, P,0.001, n=90),
providing strong support for the integrity of the microarray findings.
Real time cell assay (RTCA) to assess effectiveness of
dsRNA interference and PZQ
Based on microarray data, and then validated by qPCR, we
selected five genes that showed a high level of differential expression
after exposure to PZQ. The selected candidate genes (Contig02253
Multidrug resistance protein, Contigs05840/02748 ABC transporter H family
member 2) or Ca2+-dependant/modulatory functions (Contig10357
Calretinin, Contig01285 Calcium/calmodulin-dependent protein kinase type II
delta chain) (Figure S1) have also been shown to function in either
putative drug resistance or detoxification. In general, these genes
exhibited increased up-regulation in adult males of S. japonicum
compared with female worms, a result correlating with our hypothesis
that transcriptional responses to PZQ in schistosomes are sex-specific.
Subsequently, the impact of these five genes on adult worm
survivalibity following drug exposure was evaluated by RNAi, all of
which resulted in knockdown, which in the case of CamKII (Ca2+/
calmodulin-dependent protein kinase II) reached ,60% (female
69%, 63%, 57%; male 61%, 59% and 50%, in triplicate experiments)
when compared with irrelevant (luciferase) controls. The other four
candidate genes either did not exhibit marked or as consistent
knockdown (not shown) compared to CamKII. Gene silenced worms
were examined in motility assays to identify phenotypical differences.
Table 1. Numbers of differentially expressed genes in male and female Schistosoma japonicum after in vivo exposure to
praziquantel.
Number of differentially expressed genes (relative to 0 hours). Time point (hours) and number of differentially expressed genes
0.5 4 12 24
Male, Up-Regulated 1519 2450 2295 2735
Female, Up-Regulated 40 233 667 501
Male, Down-Regulated 145 382 1000 862
Female, Down-Regulated 1112 3138 2464 3431
doi:10.1371/journal.ppat.1003254.t001
Figure 1. Overview of genes transcriptionally up-regulated in Schistosoma japonicum in response to in vivo exposure to praziquantel.
Broad functions known to be important to schistosome biology, and specific example genes are presented. Responses were noted separately for
male and female parasites, and were classified as either ‘‘Early Phase’’ representing time points 30 min and 4 h, or ‘‘Late Phase’’ representative of 12 h
and 24 h, after administration of praziquantel. Up-regulation of genes was considered relative to pre-drug administration.
doi:10.1371/journal.ppat.1003254.g001
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The IC50 values for PZQ-treated female and male S. japonicum
were calculated from motility index analysis using the xCELLigence
system (Figure 3). Male and female worms were exposed to 12.3, 37,
111, 333, 1000, 3000 ng/ml PZQ in CSM after which motility was
monitored for up to 72 h. After 48 h, 20 ng PZQ/ml reduced
movement by,50% in both male and female worms (Figure 3A, B).
To ensure the worms used for PZQ treatment were alive at 48 h
after dsRNA electroporation, motility was measured by xCELLigence
Figure 2. Calcium Signalling Pathway according to KEGG for S. japonicum with corresponding heat maps indicating differential
gene expression ($ or #2 fold) after in vivo exposure of adult male and female parasites with praziquantel for 0, 0.5, 4, 12, 24 h.
CamKII is marked with a yellow star.
doi:10.1371/journal.ppat.1003254.g002
Figure 3. IC50 value from real time cell assay of female and male S. japonicum treated in vitro with praziquantel. Praziquantel dose
response curves used to generate IC50 values generated from motility index analysis. Panel A: Female worms, Panel B: Male parasite. Error bars (SEM)
was shown in the figure every 4 h after been treated with different concentration of praziquantel (0, 12.3, 37, 111, 333, 1000, 3000 ng/ml).
doi:10.1371/journal.ppat.1003254.g003
CamKII and Schistosome Responses to Praziquantel
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for 3 h before addition of the drug; the range (% relative to un-
electroporated parasites) of motility was for females 86–89% and 85–
110% for males (Figure 4). No differences were apparent (p-
value.0.05) among motility of CamKII and luciferase knockdown
groups for both females and males, before addition of PZQ. Only
living worms were retained for a further culture in the presence or
absence of PZQ and subsequent calculation of the average motility
index. Figure 5 shows the changes in the motility of adult males and
females with about 60% CamKII knockdown in controls (no PZQ,
Figure 5A, B) and with the addition of IC50 concentrations of PZQ
(5C, D), over 72 h. Worms exhibited decreased motility immediately
upon addition of PZQ and, in males, this was followed by spasmodic
contraction during e then five hours (Figure 5C, Figure 5D).
Worm motility in the luciferase control groups was consistently
maintained at 50–60% in the presence of PZQ, whereas CamKII
knockdowns of both male and female parasites displayed further
reduction in motility after incubation with IC50 PZQ (Figure 5).
With the addition of IC50 PZQ over 72 h (Figure 5C, Figure 5D),
the motility of male worms with CamKII knockdown, relative to
luciferase controls, decreased significantly from 61% to 23%; in
female parasites motility was reduced from 47% to 27%. Statistical
differences of paired treatments at each time point (p-value#0.05)
for both male and female parasites, between knockdown groups,
was apparent from ,40 h post PZQ administration, and generally
continued until the conclusion of the assay. These results indicated
that female and male S. japonicum worms, with reduced CamKII
Figure 4. Motility (%) of female and male S. japonicum after being electroporated with dsRNA for 48 h–51 h. Motility % is presented on
the left y-axis while the corresponding p-value is presented on the right y-axis. Panel A: Female worms, Panel B: Male parasite. Error bars (SEM) was
shown at time points, 0, 1, 2 and 3 h.
doi:10.1371/journal.ppat.1003254.g004
Figure 5. Motility (%) generated by CamKII gene knockdown, female and male worms incubated without or with praziquantel for
up to 72 h. Motility % is presented on the left y-axis while the corresponding p-value is presented on the right y-axis. For both sexes, knockdown
resulted in no significant changes in mobility without praziquantel treatment. Panel A: Female worms, Panel B: Male parasite without praziquantel
treatment. However for both sexes, knockdown leads to less motile worms in the presence of praziquantel. Panel C: Female worms, Panel D: Male
parasite with praziquantel treatment. Error bars (SEM) was shown in the figure every 4 h after been treated with or without praziquantel.
doi:10.1371/journal.ppat.1003254.g005
CamKII and Schistosome Responses to Praziquantel
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levels, were sensitive to IC50 PZQ treatment in terms of motility,
and both sexes demonstrated a CamKII-dependence in mitigating
the effects of PZQ.
Discussion
This study reports transcriptional and functional approaches to
defining the molecular responses of schistosomes to PZQ. We
demonstrate the functionally utility of the xCELLigence system to
provide real time assessment of motility, a key phenotype of adult S.
japonicum after PZQ treatment. The findings suggested that specific
inhibitors of CamKmay increase efficacy of PZQ and that a focus on
prospective drug targets in the Calcium Signalling Pathway could
facilitate development of improved or alternative anti-schistosomals.
Exposure to anti-parasitic compounds can result in diverse
outcomes in terms of the modulation of gene expression. For
example, with Plasmodium falciparum, chloroquine induces rela-
tively few transcriptional changes (,100 genes) [19], whereas
exposure to artesunate results in ,400 regulated gene alterations
[20]. A microarray-based study of Trypanosoma brucei [21] revealed
that exposure to thiazolidinediones, and the resultant cellular
differentiation, could be attributed to up-regulation of the
expression site associated gene 8 (ESAG8). In S. mansoni, genes
such as glutathione S-transferase, are up-regulated in response to
xenobiotics [22].
Adult worms of S. japonicum respond immediately to exposure
to PZQ. A notable feature is rapid disruption of the tegument to
expose surface antigens, which has also been linked to
perturbation of calcium ion homeostasis [23]. The worms
contract, a feature clearly visible to the naked eye, and surface
blebbing and other damage is evident by light or electron
microscopy [24–26]. The concentration of PZQ examined in
our study (20 mg/ml) was ,1000 fold less than that described by
Xiao and colleagues [27] who examined tegumental damage in
S. japonicum adults exposed in vitro to the much higher
concentrations of 10–30 mg/ml. Xiao and colleagues [27] were
able to detect the formation of surface blebs in worms using light
microscopy; by contrast, this damage was not apparent in any of
the worms examined here (not shown) and we conclude that
tegumental damage by PZQ did not occur in control or CamK
knockdown parasites.
Our approach to understanding the mechanism of action of
PZQ, follows that of others who have investigated the responses of
yeast and other microbes in which immediate transcriptional
changes occur, reflecting the mode of action of antimicrobial
agents [28]. The combination of chemotherapeutic and host
immune effects on the schistosomes [17,18] provides an unique
insight into the complete action of PZQ. Our in vivo model
involved the administration of PZQ to schistosome-infected mice
followed by transcriptional analysis of the drug-exposed flukes.
The gene expression profiles, which have not been reported
previously, demonstrate a polarised response between male and
female worms (Table 1 and Table S2).
We hypothesise that schistosomes up-regulate genes to com-
pensate for the effect of PZQ. This phenomenon mirrors that of
drug-treated human cells which leads to complex responses upon
the binding target [29]. It addition it is apparent that known
mechanisms occur which produce a positive feedback loop that
modulates the expression level of the respective target protein [29].
Key biological functions associated with ensuring schistosome
worm integrity were identified in the transcriptome analysis
(Figure 1; Table S1). In adult males, up-regulated genes included,
but were not limited to, those associated with tegument and
muscle function, lipid and ion regulation, and drug resistance.
Whereas fewer genes were up-regulated in females, biological
functions related to pathogen defence, general detoxification, drug
resistance and Ca2+ regulation were prominent.
The schistosome tegument provides structural and functional
elements for nutrient uptake and physical and immunological
protection, processes for which many components have been
identified by other methods including proteomic analysis [30,31].
Tegument-associated genes up-regulated in male S. japonicum
included annexins (Contigs00538 and 04019), glucose transporters
(Contig05129), calpain (Contig05997), tetraspanins (Contig00678
and 04880) and sodium/potassium-transporting ATPase (Con-
tig05103). Also up-regulated were cytoskeletal components,
including tubulin (a, b and d, Contigs 00204, 00027 and 06580),
actin (Contig05360); talin (Contig05315) and supervillin (Con-
tig03361), regulatory elements such as microtubule-actin cross-
linking factor 1 (Contig06241) and actin cytoskeleton-regulatory
complex protein (Contig02825), and muscle components such as
paramyosin (Contig07435), myosin (Contig13962) and actin
(Contig05360). Components of the basement membrane, another
important tegument structure, including laminin (Contig02502),
collagen (Contig06926) and a basement membrane-specific
heparin sulfate proteoglycan core protein (Contig11129), were
up-regulated early in the response to PZQ by male worms,
possibly reflecting tegument stress. Ultrastructural analysis of S.
mansoni worms has shown that damage to the basement membrane
is characteristic of schistosomes exposed to sub-optimal dosages of
PZQ [32].
Endocytosis across the schistosome tegument, particularly in
males, is a major route of nutrient uptake [33]. Dynamin
(Contig01607) and myoferlin (Contig07932) are components of
endocytosis within both endothelial and muscle cells of mammals
[34]. Both genes were up-regulated in male S. japonicum in response
to PZQ, suggesting increased tegument activity. This notion was
also supported by the over expression of clathrin heavy chain 1
(Contig04218) and phosphatidylinositol-binding clathrin assembly
protein (Contig07474), both of which are structural components of
coated pits [35]. Thus, while a sub-lethal dose of PZQ appeared to
place some facets of tegumental function under stress, resulting in
an increase in cytoskeletal elements, other specific processes such
as active vesicle-mediated transport appeared to increase.
Ion regulation, drug resistance and immunological defences
were phenomena where differential gene expression was promi-
nent for both male and female S. japonicum. The majority of the
genes within the KEGG Calcium Signalling Pathway were differen-
tially expressed, generally resulting in an up-regulation in males
and down-regulation in females (Figure 2; Table S4). The effect of
PZQ on Ca2+ homeostasis is well documented [3,5], and is
confirmed by these findings. However, we show also that the
impact on related pathways appears to be sex-specific. Our
transcriptional analysis of S. japonicum expands on the findings of
Aragon et al. [14] who studied the gene expression of S. mansoni
exposed in vitro to PZQ. In contrast, we used a mouse model to
analyse in vivo exposure to PZQ in adult S. japonicum. In addition,
we performed microarray analyses separately on male and female
worms, facilitating description of distinct profiles for each gender.
Similarities in the findings of the two studies are, however, evident
including the up-regulation of calcium-associated genes (such as
Contigs 03004, 08226, 09553) in male schistosomes. Additionally,
other ion-associated genes, including those for sodium (Contigs
05931, 0513, 03882) and potassium (Contigs 10776, 10915,
05103, 02734), were up-regulated in both schistosome species. The
induction of extracellular superoxide dismutase precursors (Con-
tig04124, 00246), shown in worm pairs of S. mansoni [14], was only
apparent in female S. japonicum. In the calcium pathway, many
CamKII and Schistosome Responses to Praziquantel
PLOS Pathogens | www.plospathogens.org 6 March 2013 | Volume 9 | Issue 3 | e1003254
Ca2+-mediated events occur when the released Ca2+ binds to and
activates the regulatory protein calmodulin (Contig10880), which
was strongly up-regulated in both female (93-fold increase) and
male (11-fold increase) S. japonicum at 24 h post-PZQ treatment in
vivo. In mammals, calmodulin is thought to activate CamKII
(Contig01285) by binding calcium ions [36]. From our findings
calmodulin appears as an important component of calcium
signaling and in response to PZQ strong up-regulation. However,
we did not initially select calmodulin for RNAi since it directly
interacts with multiple genes (at least 7 genes downstream) within
the pathway, and its knockdown may have presented a much more
complicated phenotype. We intend to focus on calmodulin, now
that we established protocols and have characterised CamK as a
basis for future work.
Other differentially up-regulated genes of note included those
encoding mucins (Contigs 04112, 08178 and 07699), a family of
proteins which, in schistosomes, may play a role in immune
evasion and other host-parasite interactions [37]. Mucins have
been shown to be expressed only in the intra-molluscan stages of S.
mansoni [37] and in the egg, miracidium and sporocyst stages of S.
japonicum [38]. Their up-regulation, in male and female S. japonicum
after PZQ exposure is the first indication that mucins are utilised
by the mammalian stages as well. The anti-microbial peptide b-
defensin (Contig07230) is a key host defence peptide in human
neutrophils, and a component of innate immunity, and related
peptides perform similar roles for other vertebrates and in
invertebrates, fungi and flowering [39]. For example, it serves as
anti-microbial role in Caenorhabditis elegans and Ascaris suum [40].
The current findings represent the first report of up-regulation of
this gene in adult schistosomes and may reflect a defense response
of the tegument to insult. The identification of these two defence
responses in schistosomes emphasises the utility of the in vivo PZQ
assay presented here.
A central feature of the transcriptional changes in S. japonicum
subjected to PZQ in vivo was the up-regulation of ABC
transporters, putative detoxification and multidrug resistance
genes. The up-regulation of the ATP-dependent efflux pump
SMDR2 in PZQ-treated S. mansoni in vitro [6,7] was mirrored in
the S. japonicum homologue Contig02253 (Multidrug resistance
protein 3) which, in male parasites, was up-regulated ,4-fold by
four hours after drug treatment. The role of peroxiredoxins
(Contigs01526 and 11579) in schistosomes has been linked to
detoxification, specifically in restricting oxidative damage [41].
Oxidative stress in S. japonicum described here may result from the
indirect action of PZQ or to immune-mediated damage or a
combination of the two.
Efficacy of anthelmintic action can be unambiguously quanti-
fied by ascertaining worm motility [42,43]. To ascertain the real
time efficacy of PZQ on S. japonicum, we employed the
xCELLigence approach recently pioneered by Loukas and
colleagues to quantitatively characterize effects of anti-worm drugs
by determining worm movements in real time [44]. This system
measures conductivity indicative of worm surface contact with the
gold electrodes on the surface of the culture plate. The sensitivity
of xCELLigence allowed detection of subtle changes in motility in
real time for numerous individual worms. Since each worm was
contained in a single well, producing its own signal representing
motility, this delivered statistically robust observations. To
determine a sub-lethal concentration with a 50% reduced motility
phenotype, PZQ was used in vitro to establish the IC50 of 20 ng/
ml. This IC50 is similar to that used in other studies with
schistosomes [6,7]. It has been demonstrated that when schisto-
somes are exposed to PZQ in vitro, they undergo a rapid influx of
calcium ions [45] accompanied by intense muscular paralysis in
male worms. This expected response was evident using the
xCELLigence approach. The extent of Ca2+ overload in
mammalian cells is partly mediated by the actions of CamKII,
which also participates in regulation of muscle contraction in [46].
Isolated muscle cells from S. mansoni exhibit Ca2+-dependent
contractility [47] but the effect that CamKII has on this process,
until now, not been determined. Responsive to fluctuations in
Ca2+, CamKII functionally modulates many ion channels and
transporters in mammalian cells [48]. CaMKII, which exhibits
amino acid sequence similarity to the CaMKII auto-inhibitory
domain [49], phosphorylates the b2a subunit of voltage gated
Ca2+ channels to facilitate Ca2+ channels. CamKII is necessary for
Ca2+ homeostasis in mammalian cells and it likely has a similar
function in schistosomes, a role particularly important after PZQ
exposure.
PZQ produces a well-documented effect on intracellular Ca2+
levels in adult schistosomes [50]. Contigs 01107 and 01396, both
representing potentially Voltage-dependent calcium channel subunit alpha,
were up-regulated in males but down-regulated in female S.
japonicum when exposed to PZQ in vivo. The increase in
intracellular calcium stimulates activity of the calcium-sensitive
proteins, CamKII and protein kinase C (PKC) [51], both of which
are involved in the calcium pathway and potential drug targets.
PKC (Contig07198, Protein kinase C-like 2), which can act by
phosphorylation on voltage-gated Ca2+ channel subunits [52,53],
was up-regulated in both male and female S. japonicum worms in
late response to PZQ. CamKII is known to act on both a and b
subunits of voltage-gated Ca2+ channels, resulting in the modu-
lation of ion entry into cells [49]. The increase in transcription of
both of these kinases in S. japonicum suggests that these genes act as
a response element to increase Ca2+ levels, a known event in PZQ
action. It is also apparent that both PKC and CamKII can act on
calcium channels themselves. It may be that the interaction with
CamKII is needed to restrict the effects of PZQ in schistosomes
and when CamKII is reduced, as represented here by RNAi, the
motility effects of PZQ are exacerbated. Our data also suggest that
a combination of PZQ with CamKII inhibitors such as STO-609
[54], may be synergistic for anti-schistosomal efficacy. However, S.
japonicum CamKII shares similarity with both human and murine
homologs (CAB65123.1: 81% identify, 5e-113 evalue,
NP_076302.1: 81% identify, 1e-112 evalue, as determined by
Basic Local Alignment Search Tool BLASTp [55]) and thus
deployment of inhibitors in the clinic would require careful
scrutiny.
Our results partially supports findings of a recent comparison of
gene transcription in S. mansoni worms exposed to PZQ in vitro
[16]. Cunningham and co-workers exposed worms to PZQ in a
similar time course to that presented here, where their 1 h and
20 h exposures [18] are comparable to the present study’s 0.5 h
and 24 h intervals. In juvenile S. mansoni, 1329 genes at 1 h and
3482 at 20 h were differentially up-regulated, as were 208/ND
and 1393/1223 at 1 and 20 h in adult male/female worms [18].
In both developmental stages of S. mansoni there was greater
differential expression at the later time point, a similar outcome to
the present findings. Furthermore, comparison between adult S.
mansoni male and female parasites showed limited overlap between
the sexes - only 20% of same genes were regulated in the same
direct (up or down) for both sexes. Although numerous genes were
identified in both studies, including ABC transporters, multi-drug
resistance genes, and calcium signaling pathway members, many
were observed only in juvenile S. mansoni, in contrast to the current
findings where numerous S. japonicum genes in adults were
differentially expressed in response to PZQ.
CamKII and Schistosome Responses to Praziquantel
PLOS Pathogens | www.plospathogens.org 7 March 2013 | Volume 9 | Issue 3 | e1003254
RNAi has been used to suppress a number of schistosome genes
so as to investigate their function, but many may not be amenable
to exogenous RNA interference [56]. This likely relates to
developmental and tissue specificity of the genes. Moreover,
refractoriness to RNAi may be due to the secondary structure of
transcripts, gene dosage and pathway member redundancy.
Moreover, as an informative example of the subtlety of RNAi
analysis in schistosomes, whereas suppression of the TGF-b
homologue SmInAct lead to a modest 40% suppression at the
RNA level, eggs produced by SmInAct knockdown females failed
to develop [57]. Accordingly, for other targets in addition to
CamKII, we plan in future studies to examine alternative
approaches including shRNAi [58,59].
The data presented here provide new insights into the
mechanism of action of PZQ, and the response of schistosomes
to the drug. Future investigation will focus on elucidation of the
roles of those genes, either as the direct target of PZQ or as
member of pathways that are affected by the binding of the drug
to its targets. Understanding the emergence of drug resistance in
schistosomes requires characterisation of the mode of drug action.
If resistance is associated with a mutation of the target(s),
identification of other targets within the pathway, demonstrated
as critical to parasite survival, would be informative for
development of next generation anthelmintics. We re-emphasise
that PZQ is the only drug effective against all schistosome species.
Should drug-resistance develop, the public health implications
would be considerable.
Materials and Methods
Ethics statement
The conducts and procedures involving animal experiments
were approved by the Animal Ethics Committee of the Queens-
land Institute of Medical Research (project number A0108-054).
This study was performed in accordance with the recommenda-
tions in the Guide for the Care and Use of Laboratory Animals of
the National Institutes of Health.
Collection of PZQ-treated worms in vivo (sub-lethal
effects)
Forty BALB/c mice (female, 6 weeks old) were infected with 30
S. japonicum (Anhui, China isolate) cercariae. Six weeks later, 20 of
the mice were given a single oral dose of PZQ (300 mg/kg in
PBS); the other 20 received PBS. Mice (five per group) were
euthanised at four time points (30 min, 4 h, 12 h and 24 h after
administration of PZQ or PBS and adult worms recovered by
portal perfusion using RPMI 1640 medium at 37uC [38,60]. The
half-life of PZQ in mice is 1–1.5 h [61], and visual effects on the
parasite have been reported after 15 min, post subcutaneous
administration [32]. Male and female worms were washed
separately in 37uC RPMI 1640, pooled for each time point, and
stored at 280uC prior to RNA extraction. All parasites were motile
at time of storage.
RNA isolation/labelling and microarray analysis
Male and female adult parasites were separated, pooled (8–10
worms per mouse), stored in RNAlater (Ambion) at 220uC before
microarray analysis. Total RNA was isolated from the pooled
frozen parasites [62]. RNA quality/quantity was determined using
the Bioanalyzer RNA Nano LabChip (Agilent Technologies) and
NanoDrop (Thermo Scientific). Labelling (CY3 Agilent One-
Color Amp Labeling Kit) and hybridisation methods (Agilent
One-Color Microarray-Based Gene Expression Analysis Protocol)
were carried using optimised procedures [38].
A 4644 k feature format microarray was constructed using the
S. japonicum (Anhui, China isolate) transcriptome [63] by Agilent
Technologies custom design and manufacturing pipeline. The
array comprises 60-mer oligonucleotide probes for 14,171 SjC
contiguous target sequences (Contigs) laid out in triplicate, in
addition to proprietary positive and negative controls as supplied
by the eArray software interface with Agilent’s control grid. Details
of the microarray design are available at www.ncbi.nlm.nih.gov/
geo/;Platform Accession No. GPL9759 and in Table S5 Series
Accession No. GSE41149. Applications of the array for studying
different aspects of the biology of S. japonicum have been described
[38,64]. Experiments were conducted using an Agilent one-colour
protocol and scanned on an Agilent microarray scanner at
550 nm.
Feature extraction, data analysis
Images from the DNA Microarray Scanner were extracted with
Feature Extraction (v10.5). Automatic outliner flagging was used
and the list filtered on the basis of p-value generated. Feature-
extracted data were analysed and visualised using GENESPRING
(version 11; Agilent Technologies). Microarray data were normal-
ised using a scenario for ‘Agilent FE one-color’ and Processed-
Signal values were determined using Feature Extraction and
GeneSpring microarray software, including signal to noise ratio,
spot morphology and homogeneity. ProcessedSignal represents the
signal after localised background subtraction and includes
corrections for surface trends. Features were deemed ‘Absent’
when the processed signal intensity was less than twice the value of
the processed signal error value. Features were deemed ‘Marginal’
when the measured intensity was at a saturated value or if there
was a substantial amount of variation in the signal intensity within
the pixels of a particular feature. Features that were neither absent
nor marginal were deemed ‘Present’. Data points were included
only if they were present or marginal, and probes or Contigs were
retained if at least half of the data points were ‘Present’.
Differential probe hybridisation was statistically evaluated as a p-
value, and a cut-off value of #0.05 in at least 4 of 10 conditions
used as the confidence level. Samples were normalised to
untreated parasites at time point equals 0, and expressed as a
relative fold change on a log2 scale. Microarray data were analysed
using GeneSpring and calculated p-values were used to filter data
(#0.05), carefully considering false-positive results. Multiple testing
techniques available via GeneSpring were used including the
Benjamini and Hochberg False Discovery Rate [65,66]. KEGG
(Kyoto Encyclopedia of Genes and Genomes) metabolic pathways
were considered for the microarray data [67] which have been
mapped for S. japonicum [68].
Real-time PCR
The expression profiles of a subset of genes identified during the
analysis were validated by real-time PCR. Total RNA samples
were DNase-treated (Promega, Annandale, Australia) before
complementary DNA (cDNA) synthesis [69]. The SuperScriptTM
III protocol with p(dT)15 primers was used to synthesise cDNA.
Real-time PCR was performed and analysed as described [60].
Primers used are presented in Table S6; each sample was checked
for primer dimerisation, contamination or mis-priming through
inspection of its dissociation curve. Contig01379 (DNA double-
strand break repair rad50 ATPase) was used as a reference gene
for quantitative PCR analyses as the microarray analysis showed
constitutive levels of expression of this gene at all time points for
both male and female worms after exposure to PZQ. Two
independent experiments (from cDNA synthesis) were carried out
for the validation of selected genes. Data from the microarray and
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real time PCR analyses were examined to ascertain if they fitted
normal distributions using the D’Agostino and Pearson omnibus
and the Shapiro-Wilk normality tests. Statistical analyses were
conducted using GraphPad Prism V5 or Microsoft Excel.
RNAi
Further characterisation of gene function was carried out using
RNAi, an approach now feasible for schistosomes, in light of
recent advances in knocking down schistosome genes [70,71].
RNAi was used in conjunction with an in vitro assay where S.
japonicum worms were cultured in the presence of PZQ, so as to
clarify the role of specific genes associated with drug action or in
PZQ resistance mechanisms. BALB/c mice (females, 6 weeks old)
were challenged with 30 S. japonicum (Anhui, China isolate)
cercariae. Six weeks post-infection mice were euthanised and adult
worms obtained by portal perfusion using 37uC RPMI 1640
medium. Adult worms were incubated in complete schistosome
media (CSM) containing RPMI 1640 medium, supplemented with
20% (v/v) heat-inactivated fetal calf serum, 100 IU/ml penicillin
and 100 mg/ml streptomycin, at 37uC in an atmosphere of 5%
CO2 in air overnight [72]. dsRNAs were transcribed in vitro from
template PCR products using gene-specific primers tailed with the
T7 promoter sequence. Briefly, luciferase dsRNA (dsLUC) was
used as a negative control, as reported in other studies with
schistosomes [70,71]. dsRNA of CamKII (contig01285) was
synthesised from S. japonicum cDNA using gene-targeted primers
containing T7 promoter sequences:
(F: 59-TAATACGACTCACTATAGGGAGAGAAGATGGC
TACTTCTGTACTCC-39;
R: 59-TAATACGACTCACTATAGGGAGATTCCATACG
GTTCTTTGCGTAAAA-39).
dsRNA was synthesised and purified using a Megascript RNAi
kit (Ambion). Five pairs of worms in 50 ml electroporation buffer
[73], containing 0.5 mg/ml long dsRNA, were electroporated in a
4 mm cuvette by applying a square wave with a single 20 ms
impulse at 125 v [74]. Following electroporation, parasites were
transferred to 150 ml pre-warmed (37uC) CSM. After overnight
culture, media were replaced with 300 ml of CSM. Worms were
collected at 48 h post-treatment with dsRNA, and male and
female worms were separated for total RNA extraction. Gene
transcript levels were measured by real time PCR, with NADH-
ubiquinone reductase included as the reference gene [38].
Motility assay for schistosomes
Adult worms were perfused from mice with 37uC RPMI, as
described above for RNAi. The motility of adult male or female S.
japonicum and IC50 values were assessed using the xCELLigence
system (Roche Inc.) [44]. RTCA controller software (Roche Inc.)
was used to determine how the information was gathered from the
96 well E-plate (Roche Inc.). For real-time monitoring of parasite
motility, individual female or male worms were cultured in vitro in
a 96 well E-plate (one worm per well). Each worm was cultured in
180 ml of CSM per well and motility was monitored every
15 seconds for 3 h to obtain a baseline motility (to identify healthy
parasites) reading prior to the addition of 20 ml of a 106 solution
of PZQ (stock solution in 100% ethanol at 5 mg/ml). Before the
motility of multiple parasites in a treatment group was combined
to produce an average and standard deviation (SD), we manually
curate the data to identify any worms that had died or was severely
damaged by handling either at the baseline collection or during
the subsequent culture. As such the data from that specific e-plate
well (representing the dead parasite) were removed from further
analysis. The motility index of each worm was calculated, for the
3 h prior to the addition of PZQ, as the SD over 150 data points of
the cell index (CI) difference from the rolling average (average of
the 10 proceeding and preceding CI values - 5 min total) over 20
data points [44]. For generation of the IC50 of PZQ in vitro, a final
working concentration range of 12.3–3,000 ng/ml PZQ was used
(Figure S2). After addition of PZQ, worms were monitored every
15 seconds for a further 72 h; motility index was calculated as the
SD over 800 data points, and the CI difference from the rolling
average over 20 data points. We were able to use 800 data points,
and thus more accurately determine SD, due to the longer time
course of 72 h. Dead worms (heat killed) were included as
immobile controls and considered to exhibit 0% motility. Positive
control worms (without PZQ) were cultured in the presence of the
ethanol concentration equivalent to that for the highest drug
concentration, and represented 100% worm motility. A log10 (drug
concentration) versus normalised response (100%-0%) formula
with variable slope and automatic removal of outliers. Statistical
analyses were undertaken using Graphprism 5.0 [44]. The Hill
Slope and LogIC50 value were used together and compared for
significant differences using an extra sum-of squares F-test.
For RNA interference, worms were cultured for 48 h after
dsRNA treatment; individual female or male worms were
transferred to the E-plate in 180 ml medium per well to monitor
mobility, as above. Briefly, worms were monitored for 3 h to
obtain a baseline motility reading before addition of PZQ (IC50
concentration of 20 ng/ml). After adding the drug, worms were
monitored for 72 h. Worms subjected to dsRNA but not PZQ
served as knockdown controls, and allowed the differentiation of
the separate effects of PZQ incubation and RNAi on motility. The
motility index and motility (%) of treated or untreated worms were
determined as described. For each assay, 6–10 worms were
monitored simultaneously and separately for each sex and
treatment group (with or without PZQ). A t-test (two-tailed, two-
sample equal variance) for each time point was undertaken (in
Microsoft Excel) to evaluate significance of differences in motility
between treatment groups.
Supporting Information
Figure S1 qPCR validation of a subset of genes identified from
the microarray analysis. qPCR results are presented as vertical
bars, while the microarray results are presented as a continuous
line. All data are normalised to time point 0, separately for female
and male parasites.
(TIF)
Figure S2 Motility index of female and male Schistosoma japonicum
treated without or with different concentration (series dilution
from 12.3 ng/ml to 3000 ng/ml) of praziquantel for 72 h. Panel
A: Female worms, Panel B: Male parasite. Error bars (SEM) was
shown in the figure every 4 h after been treated with or without
praziquantel.
(TIF)
Table S1 Novel genes associated with praziquantel exposure of
adult Schistosoma japonicum in vivo. Early (0.5 h to 4 h) and later
(12 h to 24 h) responses for female and male parasites are
presented normalised to time point 0 (expression= 1) for each sex
as a fold ratio.
(XLS)
Table S2 All 5,097 genes that passed flag and p-value#0.05
filtering in 10 of 20 samples. Normalised data to time point 0 for
adult female and male parasites and corresponding t-test p-value
and flag result for each time point. Description of Contigs are also
included. P= present, A= absent, M=marginal. Microarray
Contig number and gene expression fold change relative for time
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point 0 for male (M) and female (F) parasites at time points 0, 0.5,
4, 12 and 24 h.
(XLSX)
Table S3 Gene expression details of early (0.5 or 4 h) and later
(12 or 24 h) differentially expressed gene after praziquantel
exposure, for both adult male and female S. japonicum parasites.
A 2 (or 0.5) fold cut off was applied. The corresponding common
gene description, microarray Contig number and gene expression
fold change relative for time point 0 for male (M) and female (F)
parasites at time points 0.5, 4, 12 and 24 h.
(XLSX)
Table S4 Gene expression details for the Calcium Signalling
Pathway (presented in Figure 2), after praziquantel exposure, for
adult male and female S. japonicum worms. The corresponding
KEGG number, common gene name, microarray Contig number
and gene expression fold change relative for time point 0 for male
(M) and female (F) parasites at time point 0, 0.5, 4, 12 and 24 h are
presented.
(XLSX)
Table S5 Microarray Design file. Description: OS=Organism
Nam, GN=Gene Name, PE=Protein Existence, SV=Sequence
Version. Systematic: Probe identifiers. Protein Identifier:
BLASTX annotation result based on protein sequence. Synonym:
probe identity. Microarray Description: BLASTn annotation
result based on nucleotide sequence.
(XLSX)
Table S6 Primers used for qPCR validation.
(XLSX)
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